Spire Healthcare Group/£SPI

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Spire Healthcare Group

Spire Healthcare Group PLC, listed under the ticker SPI, is a prominent provider of private healthcare in the United Kingdom. The company operates a network of private hospitals and clinics offering comprehensive treatment options spanning various medical fields. Founded in 2007, Spire Healthcare has established a reputation for clinical excellence and responsive patient care.

Ticker

£SPI

Primary listing

LSE

Industry

Health Care Providers & Services

Employees

15,703

ISIN

GB00BNLPYF73

SPI Metrics

BasicAdvanced
£901M
36.05
£0.06
0.70
£0.02
1.03%

What the Analysts think about SPI

Analyst ratings (Buy, Hold, Sell) for Spire Healthcare Group stock.

Bulls say / Bears say

Spire Healthcare reported an 11% increase in revenue to £1.51 billion for 2024, indicating strong growth in its core operations. (marketscreener.com)
The company achieved over £20 million in efficiency savings in 2024, surpassing initial targets and demonstrating effective cost management. (gurufocus.com)
Spire Healthcare expanded its Primary Care business by over 15% in 2024, supported by the outperformance of Vita, and secured £90 million in long-term contracts, indicating strong growth prospects. (gurufocus.com)
The company faces significant cost increases in 2025, including £30 million due to national insurance, minimum wage hikes, and rising energy costs, which could impact profitability. (gurufocus.com)
Spire Healthcare's shares tumbled 22% after posting a slight earnings miss and issuing a cautious outlook for 2025, revealing a £40 million EBITDA hit from higher employer National Insurance costs starting in April. (proactiveinvestors.com)
The company anticipates challenges in maintaining margins due to the changing payor mix and cost pressures, which could impact future financial performance. (gurufocus.com)
Data summarised monthly by Lightyear AI. Last updated on 9 Jun 2025.

SPI Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

SPI Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £SPI

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs